药物对比
Linagliptin vs Troglitazone
比较 Linagliptin 与 Troglitazone 治疗2型糖尿病。Linagliptin（DPP-4）仍在使用；Troglitazone 因肝衰竭已撤市。作用机制、风险和可获得性。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes comparing a current DPP-4 inhibitor to a historically used but withdrawn thiazolidinedione.
结论
Linagliptin is the only currently available option, as Troglitazone was withdrawn for safety reasons.
全部药物对比